The Rial to Texas blog is a great example of the type of stories that the data doesn't tell. I can't for the life of me understand why Neuren hasn't promoted some of these stories. If you want the market to believe that Trofinetide has potential, then a video of before and during treatment would say more than any data. Katelin's story would be compelling. Sure in a double blind study we don't know who is on the gear and who is on placebo, but I am sure there are ways of capturing these stories.
Neuren ain't too good at promoting their work.
- Forums
- ASX - By Stock
- NEU
- Ann: Plans for Phase 3 trial in Rett syndrome
Ann: Plans for Phase 3 trial in Rett syndrome, page-47
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.93 |
Change
0.315(2.31%) |
Mkt cap ! $1.784B |
Open | High | Low | Value | Volume |
$13.60 | $14.00 | $13.51 | $2.428M | 175.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13 | $13.92 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.93 | 723 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 28 | 13.920 |
11 | 557 | 13.910 |
16 | 6290 | 13.900 |
9 | 1278 | 13.890 |
14 | 962 | 13.880 |
Price($) | Vol. | No. |
---|---|---|
13.930 | 973 | 9 |
13.940 | 598 | 6 |
13.950 | 1129 | 6 |
13.960 | 3608 | 5 |
13.970 | 368 | 3 |
Last trade - 14.38pm 13/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online